Testing effectiveness (Phase 2)Study completedNCT03216538
What this trial is testing
Safety and Efficacy of AS101 1% Oral Solution in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Who this might be right for
Neovascular Age-related Macular Degeneration
Feramda 20